Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Surveys.
- Who it may be relevant to
- Registry conditions: Hemophilia. Basic parameters: 18 years — 65 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy. A Multicenter Cross-sectional Cohort Study
Overview
Introduction. The development of hemophilic arthropathy causes degenerative joint damage that leads to functional impairment, limiting physical activity and causing disability in patients with hemophilia. Objectives. i) To assess the level of physical activity in patients with hemophilia; ii) To identify the best predictive model for physical activity in adult patients with hemophilic arthropathy. Material and method. Multicenter cross-sectional cohort study. Eighty-eight patients will be recruited. The dependent variable will be physical activity (International Physical Activity Questionnaire). Secondary variables will be kinesiophobia (Tampa Kinesiophobia Scale), functionality (Functional Independence Scale in Hemophilia), pain intensity, and clinical, anthropometric, and sociodemographic variables.
Interventions
- Other Surveys
No intervention will be carried out in this study; the recruited patients will only complete the questionnaires provided below
Primary outcome measures
- Measurement of physical activity level [Time frame: Screening visit]
Secondary outcome measures (12)
- Measurement of fear of movement [Time frame: Screening visit]
- Measurement of degree of functional independence [Time frame: Screening visit]
- Measurement of the joint pain [Time frame: Screening visit]
- Measurement of age [Time frame: Screening visit]
- Measurement of marital status [Time frame: Screening visit]
- Measurement of educational level [Time frame: Screening visit]
- Measurement of employment status [Time frame: Screening visit]
- Measurement of hemophilia type [Time frame: Screening visit]
- Measurement of type of drug treatment [Time frame: Screening visit]
- Measurement of inhibitor development [Time frame: Screening visit]
- Measurement of weight [Time frame: Screening visit]
- Measurement of height [Time frame: Screening visit]
Eligibility criteria
Inclusion criteria
- Patients with hemophilia A or B
- Over the age of majority
- With a medical diagnosis of severe phenotype of the disease
- With a medical diagnosis of hemophilic arthropathy in the lower limbs
- Under on-demand or prophylactic drug treatment.
Exclusion criteria
- Patients who require technical aids for walking
- Patients who are dependent for activities of daily living
- Patients over the age of 60
- Patients with cognitive impairments that prevent them from understanding the questionnaires
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Spain · 1 center
- Universidad Católica San Antonio de Murcia — Murcia
Identifiers
NCT: NCT06960499 · HeActivity